Follow
Jeremy R Chapman
Jeremy R Chapman
Clinical Professor, Sydney University, Westmead Hospital
Verified email at swahs.health.nsw.gov.au
Title
Cited by
Cited by
Year
The natural history of chronic allograft nephropathy
BJ Nankivell, RJ Borrows, CLS Fung, PJ O'Connell, RDM Allen, ...
New England Journal of Medicine 349 (24), 2326-2333, 2003
24372003
Playing the end game: DNA double-strand break repair pathway choice
JR Chapman, MRG Taylor, SJ Boulton
Molecular cell 47 (4), 497-510, 2012
18802012
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
1733*2021
The DNA sequence of the human X chromosome
MT Ross, DV Grafham, AJ Coffey, S Scherer, K McLay, D Muzny, ...
Nature 434 (7031), 325-337, 2005
13812005
Cancer incidence before and after kidney transplantation
CM Vajdic, SP McDonald, MRE McCredie, MT Van Leeuwen, JH Stewart, ...
Jama 296 (23), 2823-2831, 2006
12692006
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation
BD Tait, C Süsal, HM Gebel, PW Nickerson, AA Zachary, FHJ Claas, ...
Transplantation 95 (1), 19-47, 2013
8532013
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
BL Kasiske, MG Zeier, JR Chapman, JC Craig, H Ekberg, CA Garvey, ...
Kidney international 77 (4), 299-311, 2010
8012010
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
AC Webster, RC Woodroffe, RS Taylor, JR Chapman, JC Craig
Bmj 331 (7520), 810, 2005
7832005
RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection
JR Chapman, P Barral, JB Vannier, V Borel, M Steger, A Tomas-Loba, ...
Molecular cell 49 (5), 858-871, 2013
7292013
Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology
BJ Nankivell, RJ Borrows, CLS Fung, PJ O'Connell, JR Chapman, ...
Transplantation 78 (4), 557-565, 2004
5992004
Chronic renal allograft dysfunction
JR Chapman, PJ O’Connell, BJ Nankivell
Journal of the American society of nephrology 16 (10), 3015-3026, 2005
5872005
Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis
JS Ried, J Li, XB Zuo, XD Zheng, XY Yin, LD Sun, MA McAleer, ...
Nature genetics 47 (12), 1449-1456, 2015
5852015
REV7 counteracts DNA double-strand break resection and affects PARP inhibition
G Xu, JR Chapman, I Brandsma, J Yuan, M Mistrik, P Bouwman, ...
Nature 521 (7553), 541-544, 2015
5802015
The DNA sequence and analysis of human chromosome 6
AJ Mungall, SA Palmer, SK Sims, CA Edwards, JL Ashurst, L Wilming, ...
Nature 425 (6960), 805-811, 2003
5342003
A quantitative review of heterozygosity–fitness correlations in animal populations
JR Chapman, S Nakagawa, DW Coltman, J Slate, BC Sheldon
Molecular ecology 18 (13), 2746-2765, 2009
5192009
Quality heterostructures from two-dimensional crystals unstable in air by their assembly in inert atmosphere
Y Cao, A Mishchenko, GL Yu, E Khestanova, AP Rooney, E Prestat, ...
Nano letters 15 (8), 4914-4921, 2015
4902015
The DNA sequence and biological annotation of human chromosome 1
SG Gregory, KF Barlow, KE McLay, R Kaul, D Swarbreck, A Dunham, ...
Nature 441 (7091), 315-321, 2006
4612006
Chronic allograft nephropathy: current concepts and future directions
BJ Nankivell, JR Chapman
Transplantation 81 (5), 643-654, 2006
4602006
The global role of kidney transplantation
GG Garcia, P Harden, J Chapman
The Lancet 379 (9820), e36-e38, 2012
4432012
Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials
AC Webster, VWS Lee, JR Chapman, JC Craig
Transplantation 81 (9), 1234-1248, 2006
4232006
The system can't perform the operation now. Try again later.
Articles 1–20